SCHEMBL954957

SCHEMBL954957

[C]1=NN2CC=CN=C2S1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532653 0.68
SCHEMBL766195 0.65
SCHEMBL4757733 0.55
SCHEMBL5884621 0.50
SCHEMBL8277496 0.49
SCHEMBL12520988 0.49
SCHEMBL4052707 0.49
SCHEMBL19100784 0.49
SCHEMBL5745258 0.49
SCHEMBL1691032 0.41

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10172837-B2 Insulin sensitisers and methods of treatment NAIA Metabolic, Inc. (US) 2019-01-08 US disclosed
EP-2106260-B1 INSULIN SENSITISERS AND METHODS OF TREATMENT VERVA PHARMACEUTICALS LTD (AU) 2017-12-06 EP disclosed
US-20170079960-A1 INSULIN SENSITISERS AND METHODS OF TREATMENT NAIA Metabolic, Inc. 2017-03-23 US disclosed
US-9452148-B2 Insulin sensitisers and methods of treatment VERVA PHARMACEUTICALS LTD (AU) 2016-09-27 US disclosed
US-8455432-B2 Insulin sensitisers and methods of treatment VERVA PHARMACEUTICALS LTD. (AU) 2013-06-04 US disclosed
US-20110003740-A1 INSULIN SENSITISERS AND METHODS OF TREATMENT VERVA PHARMACEUTICALS LTD. (AU) 2011-01-06 US disclosed
EP-2106260-A1 INSULIN SENSITISERS AND METHODS OF TREATMENT Verva Pharmaceuticals Ltd (AU) 2009-10-07 EP disclosed
WO-2008089521-A1 INSULIN SENSITISERS AND METHODS OF TREATMENT VERVA PHARMACEUTICALS LTD (AU) 2008-07-31 WO disclosed